Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Alkem Laboratories Ltd. ( (IN:ALKEM) ) has issued an update.
Alkem Laboratories Ltd. has announced the reopening of its trading window on August 18, 2025, following the communication of its financial results for the quarter ending June 30, 2025, to the stock exchanges. This move marks the end of the trading window closure that was in place since June 29, 2025, in compliance with SEBI regulations. The reopening of the trading window is a routine procedure that allows stakeholders to resume trading activities, reflecting the company’s adherence to regulatory requirements and transparency in financial disclosures.
More about Alkem Laboratories Ltd.
Alkem Laboratories Ltd. operates in the pharmaceutical industry, focusing on the development, manufacture, and sale of pharmaceutical formulations and active pharmaceutical ingredients. The company is known for its wide range of products, including generics, over-the-counter drugs, and nutraceuticals, serving both domestic and international markets.
Average Trading Volume: 44,162
Technical Sentiment Signal: Sell
Current Market Cap: 579B INR
For a thorough assessment of ALKEM stock, go to TipRanks’ Stock Analysis page.